KRAS and liver cancer: The expressions of HRAS and KRAS were higher in DEN/2AAF-treated rats compared to normal rats, in accordance with Zoheir et al. [103], who reported significantly upregulated HRAS and KRAS mRNA expressions in an animal model of DEN-induced hepatic cancer.